nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.05.2007 | Image of the month

Neuroendocrine tumour of the mediastinum: fusion of ¹⁸F-FDG and ⁶⁸Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation

verfasst von: C. von Falck, A. R. Boerner, M. Galanski, W. H. Knapp

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Excerpt

The diagnostic value of ¹⁸F-FDG PET is known to be limited in neuroendocrine malignancies because only poorly differentiated tumours demonstrate a markedly increased glucose metabolism [1]. ⁶⁸Ga-DOTATOC is a somatostatin analogue for highly sensitive and specific PET imaging of neuroendocrine tumours, with a high affinity for the human SSTR2 [2]. It shows promising results for the evaluation of patients with metastatic disease and the selection of patients scheduled for radionuclide therapy [3]. …

Adams S, Baum R, Rink T, Schumm-Dräger PM, Usadel KH, Hör G. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumors. Eur J Nucl Med 1998;25:79–83.CrossRefPubMed

Maecke H, Hofmann M, Haberkorn U. 68-Ga-labeled peptides in tumor imaging. J Nucl Med 2005;46 Suppl 1:172–8.

Koukouraki S, Strauss LG, Georgoulias V, Eisenhut M, Haberkorn U, Dimitrakopoulou-Strauss A. Comparison of the pharmakokinetics of ⁶⁸Ga-DOTATOC and [¹⁸F]FDG in patients with metastatic neuroendocrine tumours scheduled for ⁹⁰Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 2006;33:1115–22.CrossRefPubMed

Titel: Neuroendocrine tumour of the mediastinum: fusion of 18F-FDG and 68Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation
verfasst von: C. von Falck
A. R. Boerner
M. Galanski
W. H. Knapp
Publikationsdatum: 01.05.2007
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 5/2007
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-006-0350-9

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Neuroendocrine tumour of the mediastinum: fusion of ¹⁸F-FDG and ⁶⁸Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2007

In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter

Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”

Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

1-[11C]-acetate PET imaging in head and neck cancer—a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning

Quantification of adenosine A2A receptors in the human brain using [11C]TMSX and positron emission tomography

Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo